Effective clinical response of lung adenocarcinoma harboring EGFR 19Del/T790M/in cis-C797S osimertinib to osimertinib and gefitinib combination therapy

被引:1
|
作者
Wang, Yanyan [1 ,2 ]
Jiang, Chenchen [3 ,4 ]
Tang, Mingyue [1 ]
Li, Huiyuan [1 ]
Zhao, Cancan [5 ]
Zhao, Menglin [1 ]
Zhang, Yue [1 ]
Li, Xinwei [1 ]
Mi, Jiaqi [1 ]
Shen, Honghong [1 ]
Wang, Zishu [1 ]
Su, Fang [1 ,6 ]
机构
[1] First Affiliated Hosp Bengbu Med Coll, Dept Med Oncol, Bengbu, Peoples R China
[2] Foshan First Peoples Hosp, Dept Internal Med, Foshan, Peoples R China
[3] Univ Newcastle, Sch Biomed Sci & Pharm, Canc Neurobiol Grp, Callaghan, NSW, Australia
[4] Univ Newcastle, Sch Med & Publ Hlth, Callaghan, NSW, Australia
[5] First Affiliated Hosp Bengbu Med Coll, Dept Radiol, Bengbu, Peoples R China
[6] First Affiliated Hosp Bengbu Med Coll, Dept Med Oncol, 287 Changhuai Rd, Bengbu 233004, Peoples R China
关键词
MUTATIONS; C797S; RESISTANCE; CANCER; T790M;
D O I
10.21037/qims-22-1269
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:5362 / 5368
页数:7
相关论文
共 50 条
  • [1] Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, and cis-C797S by osimertinib, bevacizumab, and brigatinib combination therapy: a case report
    Zhao, Jing
    Zou, Ming
    Lv, Jinyan
    Han, Yingmin
    Wang, Guangzhi
    Wang, Gang
    [J]. ONCOTARGETS AND THERAPY, 2018, 11 : 5545 - 5550
  • [2] Osimertinib in Combination with Bevacizumab Fails in Advanced Lung Adenocarcinoma Harboring EGFR T790M
    Zhang, Xiaoying
    [J]. GLOBAL MEDICAL GENETICS, 2021, 08 (04): : 133 - 134
  • [3] Lung Adenocarcinoma Harboring EGFR 19del/C797S/T790M Triple Mutations Responds to Brigatinib and Anti-EGFR Antibody Combination Therapy
    Wang, Xiaofei
    Zhou, Ling
    Yin, Jiani C.
    Wu, Xue
    Shao, Yang W.
    Gao, Beili
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (05) : E85 - E88
  • [4] Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy
    Wang, Yubo
    Yang, Nong
    Zhang, Yongchang
    Li, Li
    Han, Rui
    Zhu, Mengxiao
    Feng, Mingxia
    Chen, Hengyi
    Lizaso, Analyn
    Qin, Tian
    Liu, Xiaoyan
    He, Yong
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (08) : 1369 - 1375
  • [5] Effective treatment of pulmonary adenocarcinoma harboring triple EGFR mutations of L858R, T790M, cis-G796s/cis-C797s by osimertinib, brigatinib, and bevacizumab combination therapy: A case report
    Chang, Yuan
    Liu, Shuang
    Jiang, Yanwen
    Hua, Li
    Wen, Linfang
    [J]. RESPIRATORY MEDICINE CASE REPORTS, 2022, 36
  • [6] Durable Clinical Response of Lung Adenocarcinoma Harboring EGFR 19Del/T790M/in trans-C797S to Combination Therapy of First- and Third-Generation EGFR Tyrosine Kinase Inhibitors
    Zhou, Zhen
    Zhao, Yi
    Shen, Shengping
    Gu, Linping
    Niu, Xiaomin
    Xu, Yunhua
    Zhang, Tengfei
    Xiang, Jianxing
    Mao, Xinru
    Lu, Shun
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (08) : E157 - E159
  • [7] Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer
    Arulananda, Surein
    Do, Hongdo
    Musafer, Ashan
    Mitchell, Paul
    Dobrovic, Alexander
    John, Thomas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : 1728 - 1732
  • [8] The concomitant EGFR T790M/C797S in trans and cis in three osimertinib-resistant lung adenocarcinoma patients.
    Liu, Chunling
    Li, Jidong
    Liu, Hailong
    Du, Rong
    Fang, Nan
    Zhang, Jingbo
    Tang, Yu
    Wang, Jianwei
    Wu, Qixi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [9] Benefits of Afatinib and Osimertinib in a Patient with Lung Adenocarcinoma Harboring EGFR19Del/T790M/ G724S Mutation
    Lyu, X.
    Jiao, T.
    Yang, S.
    Yang, S.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S643 - S643
  • [10] Osimertinib Depletes EGFR T790M in the Spinal Fluid of Patients with Carcinomatous Meningitis of Lung Adenocarcinoma Harboring De Novo EGFR T790M
    Senoo, Satoru
    Ohashi, Kadoaki
    Nishii, Kazuya
    Hara, Naofumi
    Kano, Hirohisa
    Ninomiya, Kiichiro
    Maeda, Yoshinobu
    Kiura, Katsuyuki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (08) : E140 - E142